Pentwater Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.7M Buy
130,000
+55,000
+73% +$23.3M 0.31% 40
2026
Q1
$35.5M Buy
+75,000
New +$37.8M 0.18% 47
2025
Q4
– Sell
-253,400
Closed -$108M – 94
2025
Q3
$108M Buy
253,400
+93,400
+58% +$36.2M 0.6% 34
2025
Q2
$61.3M Buy
160,000
+67,500
+73% +$24.3M 0.4% 46
2025
Q1
$32M Buy
+92,500
New +$29.8M 0.27% 43
2020
Q4
– Sell
-48,700
Closed -$6.07M – 248
2020
Q3
$6.07M Sell
48,700
-167,800
-78% -$20.8M 0.08% 79
2020
Q2
$21M Buy
216,500
+74,000
+52% +$7.69M 0.37% 34
2020
Q1
$12.8M Buy
+142,500
New +$18.4M 0.21% 45

Other funds holding HCA

Pentwater Capital Management's HCA Position: Q2 2026 in Review

Pentwater Capital Management increased its HCA Healthcare (HCA) stake by 73% in Q2 2026, buying an estimated $23.3M and bringing the position to 130,000 shares worth $50.7M. The position accounts for 0.31% of the portfolio, ranked #40.

Pentwater Capital Management first reported a position in HCA in Q1 2020 and has held it in 8 quarters since. The position peaked at $108M in Q3 2025. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Pentwater Capital Management held 130,000 shares of HCA Healthcare worth $50.7M as of Q2 2026.
  • Pentwater Capital Management bought 55,000 HCA Healthcare shares in Q2 2026, an estimated $23.3M.
  • HCA Healthcare made up 0.31% of Pentwater Capital Management's portfolio in Q2 2026, its #40 holding.
  • Pentwater Capital Management first reported a position in HCA Healthcare in Q1 2020 and has held it in 8 quarters since.
  • Pentwater Capital Management's HCA Healthcare position peaked at $108M in Q3 2025.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.